NFKB1 and Hepatic fibrosis: DHM enhances IFN-γ expression through the NF-κB/STAT3 pathway to improve NK cell killing, inhibits HSCs activation and significantly improves the CCL4-induced liver fibrosis (Zhou et al., 2021).